Pfizer launches patient support app to improve medication affordability and access

Pfizer launches patient support app to improve medication affordability and access

- The launch of the IUdo app helps patients on support programs by providing greater accessibility to Pfizer medications through a digitized patient journey

- Currently, the IUdo app is available to eligible patients that are part of Pfizer Patient Support Programs in Qatar and will be rolled out in other countries across Emerging Markets in the next few months

UAE — Pfizer remains steadfast in its commitment to improving the health of patients and presenting breakthroughs that can change patients’ lives. As part of that pledge, the biopharmaceutical company continues to prioritize increasing affordability and overall access to medications through its Patient Support Programs.

As such, Pfizer has launched an innovative digital platform, IUdo for the eligible patients in Qatar. The mobile app is designed to make it easier for patients on selected Patient Support Programs to access Pfizer medications. It improves both the patient and healthcare professional’s experience by speeding up program enrolment; providing seamless access to support treatment plans; increasing the scale and reach of programs to patients and allowing the support program journey to be managed directly from their phones.

The launch of the IUdo app also underscores Pfizer’s broader ambitions to leverage digital platforms and technologies that put effective